α-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: A prospective study of response prediction

BJU International

Volumn 97, Issue 5, 2006, Pages 1017-1023

  Paick, Jae Seung ^a   Ku, Ja Hyeon ^b   Shin, Jae Wook ^a   Yang, Ji Hyun ^a   Kim, Soo Woong ^a  

^a Seoul National University   (South Korea)

^b Seoul Veterans Hospital   (South Korea)

Author keywords

Bladder; IPSS; Nocturia; Urination disorders; Voiding diary

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; TERAZOSIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOCTURIA; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL MODEL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URETHRA DISEASE; URINARY FREQUENCY; URINE VOLUME; UROFLOWMETRY;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MIDDLE AGED; PRAZOSIN; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; REGRESSION ANALYSIS; TREATMENT OUTCOME; URINATION DISORDERS; URODYNAMICS;

EID: 33645752181     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06075.x     Document Type: Article

References (31)

1. van Kerrebroeck P Abrams P Chaikin D et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002 21 179 83
2. Stewart RB Moore MT May FE Marks RG Hale WE. Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc 1992 40 1217 20
3. Weiss JP Blaivas JG. Nocturia. J Urol 2000 163 5 12
4. Asplund R. Mortality in the elderly in relation to nocturnal micturition. BJU Int 1999 84 297 301
5. Yoshimura K Ohara H Ichioka K et al. Nocturia and benign prostatic hyperplasia. Urology 2003 61 786 90
6. Homma Y Yamaguchi T Kondo Y Horie S Takahashi S Kitamura T. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia. J Urol 2002 167 172 6
7. Bruskewitz RC Larsen EH Madsen PO Dorflinger T. 3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol 1986 136 613 5
8. Jackson S. Lower urinary tract symptoms and nocturia in men and women: prevalence, aetiology and diagnosis. BJU Int 1999 84 Suppl. 1 5 8
9. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 1999 84 14 5
10. Matthiesen TB Rittig S Mortensen JT Djurhuus JC. Nocturia and polyuria in men referred with lower urinary tract symptoms, assessed using a 7-day frequency-volume chart. BJU Int 1999 83 1017 22
11. Weiss JP Blaivas JG Stember DS Brooks MM. Nocturia in adults: etiology and classification. Neurourol Urodyn 1998 17 467 72
12. Hanley JA McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982 143 29 36
13. Moons KG van Es GA Michel BC Buller HR Habbema JD Grobbee DE. Redundancy of single diagnostic test evaluation. Epidemiology 1999 10 276 81
14. Lepor H Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 1993 42 36 41
15. Carter PG McConnell AA Abrams P. The significance of atrial natriuretic peptide in nocturnal urinary symptoms in the elderly. Neurourol Urodyn 1992 4 420 1
16. Andersson KE. The pharmacological treatment of nocturia. BJU Int 2002 90 Suppl. 3 25 7
17. Johnson TM 2nd Jones K Williford WO Kutner MH Issa MM Lepor H. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol 2003 170 145 8
18. McKeigue PM Reynard JM. Relation of nocturnal polyuria of the elderly to essential hypertension. Lancet 2000 355 486 8
19. Williams G Donaldson RM. Nifedipine and nocturia. Lancet 1986 1 738
20. Debruyne FM Witjes WP Fitzpatrick J Kirby R Kirk D Prezioso D. The international terazosin trial: a multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. The ITT Group. Eur Urol 1996 30 369 76
21. McCormack M Infante-Rivard C Schick E. Agreement between clinical methods of measurement of urinary frequency and functional bladder capacity. Br J Urol 1992 69 17 21
22. Homma Y Yamaguchi O Kageyama S Nishizawa O Yoshida M Kawabe K. Nocturia in the adult: classification on the basis of largest voided volume and nocturnal urine production. J Urol 2000 163 777 81
23. Tanaka Y Masumori N Itoh N et al. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia. J Urol 2002 167 2492 5
24. Okada H Kamidono S Yoshioka T et al. A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients. BJU Int 2000 85 676 81
25. Lee E Lee C. Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses. Br J Urol 1997 80 606 11
26. Nakamura S Ishiyama S Kobayashi Y Tokue A. Clinical effect of terazosin hydrochloride on benign prostatic hypertrophy: examination by whole day uroflowmetry. Jpn J Urol Surg 1992 5 447 51
27. Ebihara A Kondo K Ohashi K et al. Pharmacokinetics and pharmacological properties of terazosin hydrochloride, a new α1-blocker: a single dose study on Japanese healthy subjects. Clin Med Pharmaceut 1987 3 667 79
28. Reynard JM Cannon A Yang Q Abrams P. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol 1998 81 215 8
29. Mattiasson A Abrams P Van Kerrebroeck P Walter S Weiss J. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 2002 89 855 62
30. Asplund R Sundberg B Bengtsson P. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study. BJU Int 1999 83 591 5
31. Drake MJ Mills IW Noble JG. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol 2004 171 1199 202